Microcystic adnexal carcinoma: An immunohistochemical reappraisal

Modern Pathology

Volumn 21, Issue 2, 2008, Pages 178-185

  Hoang, Mai P ^a,d   Dresser, Karen A ^a   Kapur, Payal ^b   High, Whitney A ^c   Mahalingam, Meera ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

BerEP4; Cytokeratin 15; Desmoplastic trichoepithelioma; Infiltrative basal cell carcinoma; Microcystic adnexal carcinoma; Squamous cell carcinoma with ductal differentiation

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CD15 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYTOKERATIN; CYTOKERATIN 15; CYTOKERATIN 20; CYTOKERATIN 7; CYTOKERATIN 903; ONCOPROTEIN; PROTEIN BEREP4; UNCLASSIFIED DRUG;

ADNEXA DISEASE; ADOLESCENT; ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MICROCYSTIC ADNEXAL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TRICHOEPITHELIOMA;

EID: 38649096944     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3801000     Document Type: Article

References (42)

1. Goldstein DJ, Barr RJ, Santa Cruz DJ. Microcystic adnexal carcinoma. A distinct clinicopathologic entity. Cancer 1982;50:566-572.
2. Lipper S, Peiper SC. Sweat gland carcinoma with syringomatous features: a light microscopic and ultrastructural study. Cancer 1979;44:157-163.
3. Glatt HJ, Proia AD, Tsoy EA, et al. Malignant syringoma of the eyelid. Ophthalmology 1984;91:987-990.
4. Cooper PH, Mills SE, Leonard D, et al. Sclerosing sweat duct (syringomatous) carcinoma. Am J Surg Pathol 1985;9:422-433.
5. Alessi E, Caputo R. Syringomatous carcinoma of the scalp presenting as a slowly enlarging patch of alopecia. Am J Dermatopathol 1993;15:503-505.
6. Chiller K, Passaro D, Scheuller M, et al. Microcystic adnexal carcinoma. Forty-eight cases, their treatment, and their outcome. Arch Dermatol 2000;136:1355-1359.
7. Friedman PM, Friedman RH, Jiang SB, et al. Microcystic adnexal carcinoma: collaborative series review and update. J Am Acad Dermatol 1999;41:225-231.
8. Santa Cruz DJ. Sweat gland carcinomas: a comprehensive review. Semin Diagn Pathol 1987;4:38-74.
9. Cooper PH. Sclerosing carcinomas of sweat ducts (microcystic adnexal carcinoma). Arch Dermatol 1986;122:261-264.
10. Sebastien TS, Nelson BR, Lowe L, et al. Microcystic adnexal carcinoma. J Am Acad Dermatol 1993;29:840-845.
11. Lupton GP, McMarlin SL. Microcystic adnexal carcinoma: report of a case with a 30-year follow-up. Arch Dermatol 1986;122:286-289.
12. Nickoloff BJ, Fleischmann HE, Carmel J, et al. Microcystic adnexal carcinoma: immunohistochemical observations suggesting dual (pilar and eccrine) differentiation. Arch Dermatol 1986;122:290-294.
13. Kato H, Mizuno N, Nakagawa K, et al. Microcystic adnexal carcinoma: a light microscopic, immunohistochemical and ultrastructural study. J Cutan Pathol 1990;17:87-95.
14. Swanson PE, Cherwitz DL, Newmann MP, et al. Eccrine sweat gland carcinoma: a histiologic and immunohistochemical study of 32 cases. J Cutan Pathol 1987;14:65-86.
15. Ceballos PI, Penneys NS, Cohen BH. Microcystic adnexal carcinoma: a case showing eccrine duct differentiation. J Dermatol Surg Oncol 1988;14:1236-1239.
16. Miyamoto T, Kambe N, Nishiura S, et al. Microcystic adnexal carcinoma: electron microscopic and immunohistochemical study. Dermatologica 1990;180:40-43.
17. Wick MR, Cooper PH, Swanson PE, et al. Microcystic adnexal carcinoma. An immunohistochemical comparison with other cutaneous appendage tumors. Arch Dermatol 1990;126:189-194.
18. LeBoit PE, Sexton M. Microcystic adnexal carcinoma of the skin. A reappraisal of the differentiation and differential diagnosis of an under-recognized neoplasm. J Am Acad Dermatol 1993;29:609-618.
19. Kirchmann TT, Prieto VG, Smoller BR. Use of CD34 in assessing the relationship between stroma and tumor in desmoplastic keratinocytic neoplasms. J Cutan Pathol 1995;22:422-426.
20. Wallace ML, Longacre TA, Smoller BR. Estrogen and progesterone receptors and anti-gross cystic disease fluid protein 15 (BRST-2) fail to distinguish metastatic breast carcinoma from eccrine neoplasms. Mod Pathol 1995;8:897-901.
21. Abesamis-Cubillan E, El-Shabrawi-Caelen L, LeBoit PE. Merkel cells and sclerosing epithelial neoplasms. Am J Dermatopathol 2000;22:311-315.
22. Urso C, Bondi R, Paglierani M, et al. Carcinomas of sweat glands: report of 60 cases. Arch Pathol Lab Med 2001;125:498-505.
23. Smith KJ, Williams J, Corbett D, et al. Microcystic adnexal carcinoma: an immunohistochemical study including markers of proliferation and apoptosis. Am J Surg Pathol 2001;25:464-471.
24. Bogner PN, Su LD, Fullen DR. Cluster designation 5 staining of normal and non-lymphoid neoplastic skin. J Cutan Pathol 2005;32:50-54.
25. Nagatsuka H, Rivera RS, Gunduz M, et al. Microcystic adnexal carcinoma with mandibular bone marrow involvement. A case report with immunohistochemistry. Am J Dermatopathol 2006;28:518-522.
26. Krahl D, Sellheyer K. Monoclonal antibody Ber-EP4 reliably discriminates between microcystic adnexal carcinoma and basal cell carcinoma. J Cutan Pathol 2007;34:782-787.
27. Jih DM, Lyle S, Elenitsas R, et al. Cytokeratin 15 expression in trichoepitheliomas and a subset of basal cell carcinomas suggests they originate from hair follicle stem cells. J Cutan Pathol 1999;26:113-118.
28. Lyle S, Christofidou-Solomidou M, Liu Y, et al. The C8/144B monoclonal antibody recognizes cytokeratin 15 and defines the location of human follicle stem cells. J Cell Sci 1998;111:3179-3188.
29. Bieniek R, Lazar AJF, Photopoulos C, et al. Sebaceous tumors contain a subpopulation of cells expressing the keratin 15 stem cell marker. Br J Dermatol 2007;156:378-380.
30. Yamamoto O, Asahi M. Cytokeratin expression in trichoblastic fibroma (small nodular type trichoblastoma), trichoepithelioma and basal cell carcinoma. Br J Dermatol 1999;140:8-16.
31. Li C, Okamoto Y, Ohmura H, et al. Expresssion of cytokeratins in Warthin's tumor (adenolymphoma) of parotid glands: specific detection of individual cytokeratin types by monoclonal antibodies. Eur J Cancer B Oral Oncol 1996;32B:352-358.
32. Yada K, Kashima K, Daa T, et al. Expression of CD10 in basal cell carcinoma. Am J Dermatopathol 2004;26:463-471.
33. Pham TT, Selim MA, Burchette Jr JL, et al. CD10 expression in trichoepithelioma and basal cell carcinoma. J Cutan Pathol 2006;33:123-128.
34. Latza U, Neidobitek G, Schwarting R, et al. Ber-EP4: new monoclonal antibody, which distinguishes epithelia from mesothelial. J Clin Pathol 1990;43:213-219.
35. Beer TW, Shepherd P, Theaker JM. Ber EP4 and epithelial membrane antigen aid distinction of basal cell, squamous cell and basosquamous carcinomas of the skin. Histopathol 2000;37:218-223.
36. Tellechea O, Reis JP, Domingues JC, et al. Monoclonal antibody Ber EP4 distinguishes basal cell carcinoma from squamous cell carcinoma of the skin. Am J Dermatopathol 1993;15:452-455.
37. Swanson PE, Fitzpatrick MM, Ritter JH, et al. Immunohistologic differential diagnosis of basal cell carcinoma, squamous cell carcinoma, and trichoepithelioma in small biopsy specimens. J Cutan Pathol 1998;25:153-159.
38. Zuk JA, West KP, Fletcher A. Immunohistochemical staining patterns of sweat glands and their neoplasms using two monoclonal antibodies to keratins. J Cutan Pathol 1988;15:8-17.
39. Requena L, Kiryu H, Ackerman AB. Neoplasms with Apocrine Differentiation. Lippincott-Raven and Ardor Scribendi: Philadelphia, 1997.
40. Pujol RM, LeBoit PE, Su WP. Microcystic adnexal carcinoma with extensive sebaceous differentiation. Am J Dermatopathol 1997;19:358-362.
41. Heenan PJ. Sebaceous differentiation in microcystic adnexal carcinoma. Am J Dermatopathol 1998;20:537-538.
42. Hashimoto K. The ultrastructure of the skin of human embryos. VII. Formation of the apocrine gland. Acta Derm Venereol 1970;50:241-251.